5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Ischemic Heart Disease
Ischemic Heart Disease, commonly known as coronary artery disease, is a prevalent cardiovascular condition characterized by reduced blood flow to the heart muscle. This reduction in blood supply occurs when coronary arteries, responsible for carrying oxygen-rich blood to the heart, become narrowed or blocked due to the buildup of fatty deposits called plaques. The restricted blood flow deprives the heart muscle of oxygen, leading to chest pain or discomfort, known as angina, and, in severe cases, can result in a heart attack. Ischemic Heart Disease is a leading cause of morbidity and mortality worldwide, emphasizing the critical need for preventive measures such as a healthy lifestyle, regular exercise, and medical management to mitigate risk factors and ensure heart health.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain